Skip to main content
Clinical Trials/CTRI/2023/08/056529
CTRI/2023/08/056529RecruitingPhase 3

A randomized open labelled comparative clinical study to evaluate the efficacy of Musta Sadhita Takra Basti and Takra Basti in Grahani vis-à-vis Irritable Bowel Syndrome. - NI

Dr Ishwarakeerthi0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • ? Subjects between the age group of 21 – 65 years irrespective of gender, religion, occupation and socioeconomic status.
  • ? Subjects fit for Basti.
  • ? Subjects fulfilling the Rome IV diagnostic criteria for IBS.
  • ? Subjects who are willing to give a written consent for the treatment

Exclusion Criteria

  • ? Subjects below 21 years and above 65 years of age.
  • ? Subjects unfit for Basti.
  • ? Condition associated with inflammatory bowel disease, and other systemic illnesses that interfere with the treatment protocol.
  • ? Pregnant and lactating women.

Investigators

Sponsor
Dr Ishwarakeerthi

Similar Trials